Medtronic enrolls first patient in Fire & Ice ablation study | Regulatory Roundup January 24, 2012 By MassDevice staff Leave a Comment Medtronic’s Arctic Front cryoablation system Medtronic (NYSE:MDT) enrolled the first of up to 572 patients in its Fire & Ice trial, the largest clinical study to date to compare 2 atrial fibrillation ablation systems.